Skip to Content

Celebrex Sales Data

Rank 21 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Celebrex U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 21 5.23% 1.71%
Q3 2013 21 (1) 3.46% -9.50%
Q2 2013 22 2.85% 2.28%
Q1 2013 22 2.47% -4.90%
Q4 2012 22 2.61% 2.41%
Q3 2012 22 (9) 12.77% 3.70%
Q2 2012 31 (1) 1.43% 2.25%
Q1 2012 32 1.08% -5.42%
Q4 2011 32 (2) 1.12% 1.47%
Q3 2011 30 (2) -4.82% -4.32%
Q2 2011 28 (1) 1.25% 2.01%
Q1 2011 29

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
February 2, 2017Common Painkillers Don't Ease Back Pain, Study Finds
March 21, 2014Doctors Often Comply When Patients Ask for Advertised Drugs: Study
September 28, 2011Some Pain Meds Riskier for Cardiac Patients Than Others, Study Suggests
November 29, 2010Celebrex Shows Potential in Preventing Some Skin Cancers: Study
January 8, 2010Celebrex Might Thwart Inherited Skin Cancers
November 24, 2008Study Calls for Greater Scrutiny of 'Off-Label' Drug Use
October 9, 2008NSAIDs Might Lower Breast Cancer Risk
May 16, 2008Celebrex Shows Benefit In First-of-Its-Kind Lung Cancer Chemoprevention Trial
Hide